Leptin and PAI-1 Levels Are Decreased After a Dietary Intervention in Patients with Irritable Bowel Syndrome
- PMID: 40429752
- PMCID: PMC12111115
- DOI: 10.3390/ijms26104607
Leptin and PAI-1 Levels Are Decreased After a Dietary Intervention in Patients with Irritable Bowel Syndrome
Abstract
A diet low in fermentable oligo-, di-, and monosaccharides and polyols (FODMAP) is an established treatment for irritable bowel syndrome (IBS). The starch- and sucrose-reduced diet (SSRD) is a newer, promising diet. Nutrients influence the production of gut hormones, which affect gastrointestinal motility. This study aimed to investigate the changes in copeptin, leptin, PAI-1, C-peptide, and insulin in patients with IBS following a 4-week dietary intervention and to explore whether these hormonal levels correlated with symptom improvements. A total of 142 participants with IBS were randomized to either a 4-week intervention with the SSRD (n = 70) or a low-FODMAP diet (n = 72). Participants completed the study questionnaire, food diary, ROME IV questionnaire, irritable bowel syndrome severity scoring system (IBS-SSS), and visual analog scale for irritable bowel syndrome (VAS-IBS) at baseline and after 4 weeks and 6 months; blood samples were collected at each of these time points. Leptin levels decreased from baseline to 4 weeks in the SSRD group (p = 0.002) but not in the low-FODMAP group (p = 0.153). In the overall study population, leptin (p = 0.001) and PAI-1 (p = 0.019) levels decreased from baseline to 4 weeks. Leptin changes were mainly associated with alterations in carbohydrate intake but not with symptom changes. These findings suggest that the SSRD reduces the levels of leptin in patients with IBS, while PAI-1 levels decrease independently of the dietary intervention, without a corresponding impact on symptoms.
Keywords: C-peptide; IBS; PAI-1; SSRD; copeptin; insulin; leptin; low FODMAP.
Conflict of interest statement
The authors have no conflicts of interest.
Figures


Similar articles
-
A Starch- and Sucrose-Reduced Diet Has Similar Efficiency as Low FODMAP in IBS-A Randomized Non-Inferiority Study.Nutrients. 2024 Sep 9;16(17):3039. doi: 10.3390/nu16173039. Nutrients. 2024. PMID: 39275354 Free PMC article. Clinical Trial.
-
A carbohydrate-restricted diet for patients with irritable bowel syndrome lowers serum C-peptide, insulin, and leptin without any correlation with symptom reduction.Nutr Res. 2021 Feb;86:23-36. doi: 10.1016/j.nutres.2020.12.001. Epub 2020 Dec 4. Nutr Res. 2021. PMID: 33450656 Clinical Trial.
-
Low fermentable oligo-di-mono-saccharides and polyols diet versus general dietary advice in patients with diarrhea-predominant irritable bowel syndrome: A randomized controlled trial.J Gastroenterol Hepatol. 2018 Jun;33(6):1192-1199. doi: 10.1111/jgh.14051. Epub 2018 Feb 21. J Gastroenterol Hepatol. 2018. PMID: 29159993 Clinical Trial.
-
Low-FODMAP Diet for Irritable Bowel Syndrome: Insights from Microbiome.Nutrients. 2025 Jan 31;17(3):544. doi: 10.3390/nu17030544. Nutrients. 2025. PMID: 39940404 Free PMC article. Review.
-
Clinical application of dietary therapies in irritable bowel syndrome.J Gastrointestin Liver Dis. 2018 Sep;27(3):307-316. doi: 10.15403/jgld.2014.1121.273.avy. J Gastrointestin Liver Dis. 2018. PMID: 30240475 Review.
References
-
- Sperber A.D., Bangdiwala S.I., Drossman D.A., Ghoshal U.C., Simren M., Tack J., Whitehead W.E., Dumitrascu D.L., Fang X., Fukudo S., et al. Worldwide prevalence and burden of functional gastrointestinal disorders, results of Rome foundation global study. Gastroenterology. 2021;160:99–114. doi: 10.1053/j.gastro.2020.04.014. - DOI - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous